Gene · 5961
Papers1,698
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,698
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sex Distributions in Non-ABCA4 Autosomal Macular Dystrophies. | Invest Ophthalmol Vis Sci | 2024 | 38700873 | PubTator, text mining | PubMed |
| [Role of endosomal pathway in the ciliary transport and the membrane organization of outer segment disc membrane in photoreceptors]. | Nihon Yakurigaku Zasshi | 2024 | 38684400 | PubTator, text mining | PubMed |
| Antibody association in solution: cluster distributions and mechanisms. | MAbs | 2024 | 38666507 | PubTator, text mining | PubMed |
| Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes. | Biomolecules | 2024 | 38540785 | PubTator, text mining | PubMed |
| PRPH2-Related Retinal Dystrophies: Mutational Spectrum in 103 Families from a Spanish Cohort. | Int J Mol Sci | 2024 | 38474159 | PubTator, text mining | PubMed |
| Novel heterozygous PRPH2 variant identified in a patient with spinocerebellar ataxia type 14 and macular dystrophy. | Ophthalmic Genet | 2024 | 38419591 | PubTator, text mining | PubMed |
| Systemic advantage has a meaningful relationship with grade outcomes in students' early STEM courses at six research universities. | Int J STEM Educ | 2024 | 38404757 | PubTator, text mining | PubMed |
| Knowledge, attitude, and utilization of traditional medicine within the plural medical system in West Java, Indonesia. | BMC Complement Med Ther | 2024 | 38287364 | PubTator, text mining | PubMed |
Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes. | Prog Retin Eye Res | 2024 | 38278208 | PubTator, text mining | PubMed |
| Retinitis Pigmentosa: From Pathomolecular Mechanisms to Therapeutic Strategies. | Medicina (Kaunas) | 2024 | 38276069 | PubTator, text mining | PubMed |
| Molecular Regulation and Oncogenic Functions of TSPAN8. | Cells | 2024 | 38275818 | PubTator, text mining | PubMed |
| Spectrum of Genetic Variants in the Most Common Genes Causing Inherited Retinal Disease in a Large Molecularly Characterized United Kingdom Cohort. | Ophthalmol Retina | 2024 | 38219857 | PubTator, text mining | PubMed |
| Reprogramming biocatalytic futile cycles through computational engineering of stereochemical promiscuity to create an amine racemase. | Nat Commun | 2024 | 38169460 | PubTator, text mining | PubMed |
| Genetics of Retinitis Pigmentosa and Other Hereditary Retinal Disorders in Western Switzerland. | Ophthalmic Res | 2024 | 38160664 | PubTator, text mining | PubMed |
| An orally available Cav2.2 calcium channel inhibitor for the treatment of neuropathic pain. | Br J Pharmacol | 2024 | 38157867 | PubTator, text mining | PubMed |
| Gene Therapy for Inherited Retinal Diseases: From Laboratory Bench to Patient Bedside and Beyond. | Ophthalmol Ther | 2024 | 38113023 | PubTator, text mining | PubMed |
| Modeling fragment counts improves single-cell ATAC-seq analysis. | Nat Methods | 2024 | 38049697 | PubTator, text mining | PubMed |
| Structure-function correlation of retinal photoreceptors in PRPH2-associated central areolar choroidal dystrophy patients assessed by high-resolution scanning laser imaging and microperimetry. | Acta Ophthalmol | 2024 | 38041245 | PubTator, text mining | PubMed |
| Antineoplastic activity of GP-2250 in-vitro and in mouse xenograft models. | Anticancer Drugs | 2024 | 37983375 | PubTator, text mining | PubMed |
| Novel IMPG2 variant causing adult macular vitelliform dystrophy: A case report. | Eur J Ophthalmol | 2024 | 37661650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5961/papers?page=8